Patents by Inventor Fangmin Xu

Fangmin Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYOMAVIRUS NEUTRALIZING ANTIBODIES
    Publication number: 20230399382
    Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
    Type: Application
    Filed: March 17, 2023
    Publication date: December 14, 2023
    Inventors: Johanna ABEND, Zorica DRAGIC, Adam Lloyd FEIRE, Mark KNAPP, Steven KOVACS, Elisabetta TRAGGIAI, Lichun WANG, Yongqiang WANG, Danqing WU, Qilong WU, Fangmin XU
  • Methods of treating FGF21-associated disorders
    Patent number: 11802152
    Abstract: The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: October 31, 2023
    Assignee: Novartis AG
    Inventors: Brian Boettcher, Shari Lynn Caplan, Regis Cebe, Guochun Li, John A. Taraszka, Fangmin Xu, David Langdon Yowe
  • Polyomavirus neutralizing antibodies
    Patent number: 11639378
    Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: May 2, 2023
    Assignee: Novartis AG
    Inventors: Johanna Abend, Zorica Dragic, Adam Lloyd Feire, Mark Knapp, Steven Kovacs, Elisabetta Traggiai, Lichun Wang, Yongqiang Wang, Danqing Wu, Qilong Wu, Fangmin Xu
  • Polyomavirus Neutralizing Antibodies
    Publication number: 20220363735
    Abstract: The present invention relates to anti-VP 1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
    Type: Application
    Filed: October 15, 2021
    Publication date: November 17, 2022
    Applicant: Novartis AG
    Inventors: Johanna ABEND, Zorica DRAGIC, Adam Lloyd FEIRE, Mark KNAPP, Steven KOVACS, Elisabetta TRAGGIAI, Lichun WANG, Yongqiang WANG, Danqing WU, Qilong WU, Fangmin Xu
  • Method for distributing pilot frequency in massive antenna system
    Patent number: 11445504
    Abstract: The disclosure discloses a method for distributing pilot frequency in a massive antenna system, including: dividing a pilot frequency set into three sub sets that are intersecting with each other, and then dividing the users of each cell into a cell central user and a cell edge user. The cell central users use an intersection set of three pilot frequency sub sets. The cell edge users of all cells use a difference set, an intersection set and a union set of three pilot frequency sub sets according to a certain rule. When it is designing to implement the pilot resource distribution plan of the massive antenna system, three cells that are adjacent with each other in the system are used as a cluster, and a pilot frequency use plan of any one cluster may be designed according to the method proposed by the disclosure, and then the same design plan is applied to other clusters in the system, and then is adjusted according to the user distribution of each cluster and the business distribution circumstance thereof.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: September 13, 2022
    Assignees: SUNWAVE COMMUNICATIONS CO., LTD., BTI WIRELESS LIMITED, BRAVO TECH INC
    Inventors: Fangmin Xu, Junrong Yan, Rulong Chu, Xingbao Ou
  • METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
    Publication number: 20220185883
    Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
    Type: Application
    Filed: September 24, 2021
    Publication date: June 16, 2022
    Inventors: Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
    Publication number: 20220162300
    Abstract: The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: December 1, 2021
    Publication date: May 26, 2022
    Inventors: Brian BOETTCHER, Shari Lynn CAPLAN, Regis CEBE, Guochun LI, John A. TARASZKA, Fangmin XU, David Langdon YOWE
  • COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3
    Publication number: 20220133889
    Abstract: Combination therapies comprising antibody molecules that specifically bind to TIM-3 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
    Type: Application
    Filed: September 17, 2021
    Publication date: May 5, 2022
    Inventors: Glenn Dranoff, Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • Methods of treating FGF21-associated disorders
    Patent number: 11236159
    Abstract: The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: February 1, 2022
    Assignee: Novartis AG
    Inventors: Brian Boettcher, Shari Lynn Caplan, Regis Cebe, Guochun Li, John A. Taraszka, Fangmin Xu, David Langdon Yowe
  • Polyomavirus neutralizing antibodies
    Patent number: 11161894
    Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: November 2, 2021
    Assignee: Novartis AG
    Inventors: Johanna Abend, Zorica Dragic, Adam Lloyd Feire, Mark Knapp, Steven Kovacs, Elisabetta Traggiai, Lichun Wang, Yongqiang Wang, Danqing Wu, Qilong Wu, Fangmin Xu
  • Method of detecting TIM-3 using antibody molecules to TIM-3
    Patent number: 11155620
    Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: October 26, 2021
    Assignees: Novartis AG, DANA-FARBER CANCER INSTITUTE, INC., The Children's Medical Center Corporation
    Inventors: Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • Antibody molecules to TIM-3 and uses thereof
    Patent number: 10981990
    Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: April 20, 2021
    Assignees: Novartis AG, DANA-FARBER CANCER INSTITUTE, INC., The Children's Medical Center Corporation
    Inventors: Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • A Method for Distributing Pilot Frequency in Massive Antenna System
    Publication number: 20210099997
    Abstract: The disclosure discloses a method for distributing pilot frequency in a massive antenna system, including: dividing a pilot frequency set into three sub sets that are intersecting with each other, and then dividing the users of each cell into a cell central user and a cell edge user. The cell central users use an intersection set of three pilot frequency sub sets. The cell edge users of all cells use a difference set, an intersection set and a union set of three pilot frequency sub sets according to a certain rule. When it is designing to implement the pilot resource distribution plan of the massive antenna system, three cells that are adjacent with each other in the system are used as a cluster, and a pilot frequency use plan of any one cluster may be designed according to the method proposed by the disclosure, and then the same design plan is applied to other clusters in the system, and then is adjusted according to the user distribution of each cluster and the business distribution circumstance thereof.
    Type: Application
    Filed: March 29, 2019
    Publication date: April 1, 2021
    Inventors: Fangmin XU, Junrong YAN, Rulong CHU, Xingbao OU
  • ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
    Publication number: 20200308277
    Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
    Type: Application
    Filed: April 6, 2020
    Publication date: October 1, 2020
    Inventors: Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
    Publication number: 20200223917
    Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
    Type: Application
    Filed: September 30, 2019
    Publication date: July 16, 2020
    Inventors: Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • POLYOMAVIRUS NEUTRALIZING ANTIBODIES
    Publication number: 20200190167
    Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
    Type: Application
    Filed: October 18, 2019
    Publication date: June 18, 2020
    Inventors: Johanna ABEND, Zorica DRAGIC, Adam Lloyd FEIRE, Mark KNAPP, Steven KOVACS, Elisabetta TRAGGIAI, Lichun WANG, Yongqiang WANG, Danqing WU, Qilong WU, Fangmin Xu
  • Polyomavirus neutralizing antibodies
    Patent number: 10654914
    Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: May 19, 2020
    Assignee: Novartis AG
    Inventors: Johanna Abend, Zorica Dragic, Adam Lloyd Feire, Mark Knapp, Steven Kovacs, Elisabetta Traggiai, Lichun Wang, Yongqiang Wang, Danqing Wu, Qilong Wu, Fangmin Xu
  • METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
    Publication number: 20200087392
    Abstract: The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human ?-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
    Type: Application
    Filed: August 2, 2016
    Publication date: March 19, 2020
    Inventors: Brian BOETTCHER, Shari Lynn CAPLAN, Regis CEBE, Guochun LI, John A TARASZKA, Fangmin XU, David Langdon YOWE
  • Antibody molecules to TIM-3 and uses thereof
    Patent number: 10472419
    Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: November 12, 2019
    Assignees: Novartis AG, DANA-FARBER CANCER INSTITUTE, INC., Children's Medical Center Corporation
    Inventors: Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka, Jennifer Marie Mataraza, Walter A. Blattler, Daniel J. Hicklin, Maximiliano Vasquez, Rosemarie H. DeKruyff, Dale T. Umetsu, Gordon James Freeman, Tiancen Hu, John A. Taraszka, Fangmin Xu
  • Polyomavirus neutralizing antibodies
    Patent number: 10450366
    Abstract: The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: October 22, 2019
    Assignee: Novartis AG
    Inventors: Johanna Abend, Zorica Dragic, Adam Lloyd Feire, Mark Knapp, Steven Kovacs, Elisabetta Traggiai, Lichun Wang, Yongqiang Wang, Danqing Wu, Qilong Wu, Fangmin Xu